StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMApr 26, 2026, 05:26 AM

ARCT 2026 Annual Meeting Set for June 5; Director Elections, Say on Pay

AI Summary

Arcturus Therapeutics Holdings Inc. filed a definitive proxy statement (DEF 14A) announcing its 2026 Annual Meeting of Stockholders. The virtual meeting is scheduled for June 5, 2026, at 9:00 a.m. Pacific Time. Stockholders will vote on the election of eight directors, a non-binding advisory resolution on named executive officer compensation, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026. The record date for voting is April 14, 2026.

Key Highlights

  • Arcturus Therapeutics Holdings Inc. (ARCT) to hold 2026 Annual Meeting on June 5, 2026, at 9:00 a.m. Pacific Time.
  • The Annual Meeting will be a completely virtual meeting of stockholders.
  • Stockholders will vote on the election of 8 directors to the Board.
  • A non-binding advisory vote on named executive officer compensation will be held.
  • Stockholders will ratify the appointment of Deloitte & Touche LLP as independent auditor for fiscal year 2026.
  • The record date for stockholders entitled to vote is April 14, 2026.